# Avalo Therapeutics, Inc.: Form 8-K, filed Aug 14, 2024

- Company: [Avalo Therapeutics, Inc.](/companies/avtx.md) (CIK 1534120)
- Form: 8-K
- Filed: 2024-08-14
- Accepted by EDGAR: Aug 14, 2024, 16:01 ET
- Period: 2024-08-13
- Accession: 0001628280-24-037174
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1534120/000162828024037174/avtx-20240813.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1534120/000162828024037174/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1534120/000162828024037174/avtx-20240813.htm

Filed Aug 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-037174. Last ingested by Listed: Oct 29, 2026, 16:18 ET. No prices; not investment advice.